ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 683555 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 683555; 2) Community: the network communities that were significantly associated with the response to NSC 683555; 3) Molecule: the relationships between components within communities and NSC 683555; 4) MDR: the compounds that were significantly associated with the NSC 683555.

NSC Compound Enrichment Correlation
NSC 693543 4-Acridinecarboxamide, 9-amino-N-[3-[(2-aminoethyl)amino]propyl]-5-methyl-, trihydrochloride 0.000880521445136051 0.27575113
NSC 697194 Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dimethoxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- 0.000880521445136051 0.41534595
NSC 736201 Indenoisoquinoline derivative 0.000880521445136051 0.79165079
NSC 9706 Triethylenemelamine 0.000880521445136051 0.79440712
NSC 648114 ANTINEOPLASTIC-D648114 0.000880521445136057 0.54897969
NSC 651774 Null 0.000880521445136057 0.44115329
NSC 682298 Camptothecin Derivative 0.000880521445136057 0.85805257
NSC 700363 Liposomal Annamycin 0.000931492155975089 0.65291639
NSC 715974 Null 0.000931492155975089 0.43488523
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.000931492155975089 0.66085711
Total:89  Current:5    [First] [Prev] [Next] [Last]